Actinium Pharmaceuticals, Inc. (ATNM)
1.14
+0.03
(+2.70%)
USD |
NYAM |
May 01, 10:12
Actinium Pharmaceuticals Market Cap : 35.77M for May 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.724B |
| Alnylam Pharmaceuticals, Inc. | 40.54B |
| Savara, Inc. | 1.060B |
| BioMarin Pharmaceutical, Inc. | 10.38B |
| Imunon, Inc. | 6.005M |
Market Cap Related Metrics
| PS Ratio | 395.15 |
| Price to Book Value | 4.566 |
| Price | 1.14 |
| Earnings Yield | -95.29% |